newsfilter
← Latest News
GlobeNewswire·

ProMIS Neurosciences Shareholders Approve Special Resolution

TORONTO and CAMBRIDGE, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX:PMN) (OTCQB:ARFXF) (the "Company"), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers impli